Cardinal Investors Reach $124M Settlement In Opioid Suit

By Katryna Perera · May 26, 2022, 8:31 PM EDT

Directors of Cardinal Health Inc. and the company's investors have reached a $124 million settlement resolving claims of a shareholder derivative suit that the directors failed to protect the company from...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Cardinal Health, Inc. Derivative Litigation

Case Number

2:19-cv-02491

Court

Ohio Southern

Nature of Suit

Stockholders Suits

Date Filed

June 14, 2019